Maxwell Krakowiak Net Worth

The estimated Net Worth of Maxwell Krakowiak is at least $872 Mille dollars as of 29 March 2023. Maxwell Krakowiak owns over 322 units of Revvity stock worth over $830,319 and over the last 2 years Maxwell sold PKI stock worth over $41,860.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Maxwell Krakowiak PKI stock SEC Form 4 insiders trading

Maxwell has made over 1 trades of the Revvity stock since 2023, according to the Form 4 filled with the SEC. Most recently Maxwell sold 322 units of PKI stock worth $41,860 on 29 March 2023.

The largest trade Maxwell's ever made was selling 322 units of Revvity stock on 29 March 2023 worth over $41,860. On average, Maxwell trades about 64 units every 0 days since 2022. As of 29 March 2023 Maxwell still owns at least 7,202 units of Revvity stock.

You can see the complete history of Maxwell Krakowiak stock trades at the bottom of the page.

What's Maxwell Krakowiak's mailing address?

Maxwell's mailing address filed with the SEC is 940, Winter Street, Prospectville, Waltham, Middlesex County, Massachusetts, 02451, United States.

Insiders trading at Revvity

Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe e Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.

What does Revvity do?

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

Complete history of Maxwell Krakowiak stock trades at Revvity

Revvity executives and stock owners

Revvity executives and other stock owners filed with the SEC include:

• Dr. Prahlad R. Singh Ph.D.,
  CEO, Pres & Director
• Prahlad Singh,
  President, Chief Executive Officer, Director
• Joel Goldberg,
  Senior Vice President - Administration, General Counsel, Secretary
• James M. Mock,
  Sr. VP & CFO
• Joel S. Goldberg,
  Sr. VP of Admin., Gen. Counsel & Sec.
• James Mock,
  Chief Financial Officer, Senior Vice President
• Deborah Butters,
  Chief Human Resource Officer, Senior Vice President
• Tajinder Vohra,
  Sr. VP of Global Operations
• Alexandros Michas,
  Independent Non-Executive Chairman of the Board
• Samuel Chapin,
  Independent Director
• Peter Barrett,
  Independent Director
• Pascale Witz,
  Independent Director
• Frank Witney,
  Independent Director
• Sylvie Gregoire,
  Independent Director
• Michel Vounatsos,
  Independent Director
• Andrew Okun,
  Chief Accounting Officer, Vice President
• Tajinder Vohra,
  Senior Vice President, Global Operations
• Daniel Tereau,
  Senior Vice President, Strategy and Business Development
• Masoud Toloue,
  Sr. VP of Diagnostics
• Miriame Victor,
  Sr. VP & Chief Commercial Officer
• Robert Francis Friel,
  Advisor
• Stephen Barr Willoughby,
  VP of Investor Relations
• Andrew Okun,
  VP, Chief Accounting Officer & Treasurer
• Michelle Mc Murry Heath,
  Director
• Nicholas A Lopardo,
  Director
• James Corbett,
  See Remarks
• Alexis P Michas,
  Director
• Vicki L Sato,
  Director
• Kenton J Sicchitano,
  Director
• Robert F Friel,
  Chief Financial Officer
• Patrick J Sullivan,
  Director
• Frank Anders Wilson,
  SVP, CFO & CAO
• John A Roush,
  Vice President
• Michael Louis Battles,
  VP & Chief Accounting Officer
• Jeffrey D Capello,
  Chief Accounting Officer
• Gregory L Summe,
  Chairman & CEO
• Katherine A O Hara,
  SVP & General Counsel
• Richard F Walsh,
  Senior Vice President
• Tamara J Erickson,
  Director
• Robert A Barrett,
  Sr. Vice President
• Terrance L Carlson,
  Sr. VP & General Counsel
• Peter B Coggins,
  Sr. Vice President
• John Patrick Murphy,
  Sr. Vice President
• John R Letcher,
  Senior Vice President, HR
• Jonathan P. Di Vincenzo,
  See Remarks
• James C Mullen,
  Director
• Maurice H. Tenney,
  See Remarks
• Daniel R Marshak,
  SVP & CSO
• E Kevin Hrusovsky,
  See Remarks
• G Robert Tod,
  Director
• Gabriel Schmergel,
  Director
• Miriame Victor,
  Please See Remarks
• Maxwell Krakowiak,
  Please See Remarks